Jun 09, 2020
Arix Bioscience plc: Arix to Present at the Proactive One2One Biotech Forum
Jun 03, 2020
Arix to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
Apr 15, 2020
Arix Bioscience plc: Investment Team Changes - Jonathan Tobin, PhD, promoted to Managing Director
Jan 27, 2020
Arix Co-founds Quench Bio With Series A Financing
Sep 30, 2019
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
Sep 17, 2019
Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme
Apr 02, 2019
Arix Bioscience plc: Aura Completes $40 Million Series D Financing
Apr 01, 2019
Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR
Mar 29, 2019
Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019
Mar 18, 2019
Arix Bioscience plc: Arix Co-leads $63 Million Series B Investment Round for Imara
Feb 19, 2019
Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial
Feb 19, 2019
Arix Bioscience plc: Management and Board Changes
Feb 14, 2019
Arix Bioscience plc: Harpoon Closes Initial Public Offering
Dec 28, 2018
Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States
Dec 11, 2018
Arix Bioscience plc: Arix Appoints Dr Christian Schetter as Entrepreneur in Residence (EIR)
Dec 03, 2018
Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes
Dec 03, 2018
Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH
Nov 15, 2018
Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound
Nov 12, 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Oct 30, 2018
Arix Bioscience plc - Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011